Yating Wang, MD

CIO 2023-34 Radioembolization Plus Gemcitabine, Cisplatin, and Capecitabine as First-Line Therapy for Intrahepatic Cholangiocarcinoma

Purpose: To report outcomes of an institutional downstaging protocol for intrahepatic cholangiocarcinoma (iCCA) using radioembolization (TARE), gemcitabine, cisplatin, and capecitabine co...

Yating Wang , MD;

Mikin Patel , MD;

Thuong Van Ha , MD;

John Fung , MD;

Anjana Pillai , MD;

Osman Ahmed , MD;

Chih-Yi Liao , MD;

Talia Baker , MD;

Qian Yu , MD;

11/02/2023

Videos

Survival Trends Among Patients With Metastatic NSCLC Before and After the Approval of Immunotherapy in the US

09/27/2024

Yating Wang , MD;

Yating Wang, MD, shares the findings and future implications of her study on survival trends among patients with metastatic non–small cell lung cancer (NSCLC) before and after the approval of immunotherapy in the US.

Yating Wang, MD, shares the...

09/27/2024

Journal of Clinical Pathways